Registry study for Carillon device in leaky mitral valve
Part of Heart & circulation clinical trials.
This registry collects health information from adults who already have the Carillon device to treat a leaky mitral valve caused by dilated heart muscle. The goal is to better understand how the device performs in real-world care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have functional mitral regurgitation (a leaky mitral valve due to enlarged/dilated heart muscle)
- You already have the Carillon device implanted
- You can sign and understand informed consent to join the registry
- You have baseline heart test results from the registry plan, including: MR grade, LVEF %, LVEDD, LAD, and valve/heart measurements (AP and ML diameters), plus NYHA class
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps track of people who had NeoChord treatment to help understand how well it works in everyday care. You may be included if you had a certain type of mitral valve leakage (regurgitation) and the procedure happened after 2016.
This registry study follows people who are getting a minimally invasive heart valve repair called M-TEER. It helps doctors learn more about how well the procedure works and how patients recover.
This trial tests whether a device called the Carillon Mitral Contour System can help people with heart failure caused by a mild-to-moderate leaky mitral valve. You’d be compared against a control group, and the goal is to improve heart failure symptoms and outcomes.
This study collects and compares real-world results to help doctors choose the best treatment for mitral valve “leakiness.” If you have clinically significant mitral insufficiency and have already had a specific heart procedure screening, your echocardiogram results may be used to understand outcomes over at least a month.
This registry is testing a new, less invasive way to replace your mitral valve using a catheter. It's for people who cannot have open-heart surgery or a MitraClip, and who have a strong enough heart.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
Hear when a new Functional Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.